Letybo® in Sherman Oaks

Letybo® is an FDA-approved, Korean-developed injectable neuromodulator used to temporarily improve moderate to severe frown lines between the eyebrows. Like Botox Cosmetic, it works by temporarily reducing muscle activity. However, Letybo and Botox are different prescription products with distinct formulations, dosing requirements, and FDA-approved indications. Their units are not interchangeable.

Some patients may notice improvement as early as the first day after treatment, with others noticing changes over the following several days. In clinical studies, patients reported improvement as early as Day 1, with onset commonly occurring within approximately three days. Individual results vary.

Letybo results are temporary. Clinical studies have demonstrated treatment effects through approximately 16 weeks in some patients, with retreatment often occurring around four months. The duration depends on individual response and other treatment-related factors.

Vanity Look Skin Center in Sherman Oaks currently offers Letybo at a special introductory price of $11 per unit. The total cost depends on the prescribed number of units and any applicable fees. Your provider will determine the appropriate treatment plan during your consultation.

Yes. Letybo received FDA approval in February 2024 for the temporary improvement of moderate to severe glabellar lines, commonly called the “11 lines” between the eyebrows, in adults. It has also been approved in numerous countries internationally.

In the United States, Letybo is FDA-approved for moderate to severe frown lines between the eyebrows. These lines develop partly from repeated contractions of the muscles involved in frowning. Your provider can explain its approved indication and whether it is appropriate for your concerns.

Letybo is a nonsurgical injectable treatment, and many patients can return to routine activities shortly afterward. However, temporary redness, bruising, swelling, or tenderness may occur. Other adverse reactions are possible, including headache and eyelid or brow drooping. Follow your provider's aftercare instructions.